Muzaffar H. Qazilbash, MD, on Multiple Myeloma: Results From a Treatment Trial
Posted: Monday, December 11, 2017
Muzaffar H. Qazilbash, MD, of The University of Texas MD Anderson Cancer Center, discusses phase III study findings on busulfan plus melphalan vs melphalan alone for patients with multiple myeloma.